CD4 and neoplasm: We evaluated the expression of immune cell-specific markers (CD4, CD8 and CD68) and endocan by immunohistochemistry and correlated these findings with clinical, imaging and histopathological features and we assessed their prognostic role in correlation with tumour invasiveness and responsiveness to SSAs.